Supplemental Experimental Procedures
Human GBM specimen culture conditions
Glioblastoma ( consisting of CSC medium with 1% FBS was used for long-term studies (beyond 24 hr) whereas in short-term experiments (less than 6 hr), a null medium consisting of only NBM was used.
hES-cell derived OPCs and isolation and culture of primary Normal Glial Progenitors

Derivation of human OPCs
Human OPCs were differentiated from the human embryonic stem cell line H7 over a 154 day protocol (NIH Human Embryonic Stem Cell Registry WA07; NIH Approval Number: NIHhESC-10-0061) as previously demonstrated (Hu et al., 2009; Wang et al., 2013) . hESC-derived OPCs were characterized by co-staining of Sox10 (R&D Systems,AF2864; 1:100) and Olig2 (Millipore, AB9610 1:500).
Isolation of Normal Glial Progenitors
Normal (NM), non-neoplastic cells were derived from patient tissue specimens of neurosurgical resection in accordance with a Cleveland Clinic Institutional Review Board-approved protocol.
Informed consent was obtained by the tissue bank, which provided de-identified excess tissue to the laboratory immediately following surgical resection. Specimens used for cell culture were dissociated with a Papain dissociation kit (Worthington). Cells were cultured adherently in media containing 50% Neurobasal medium (Gibco) and 50% Dulbecco's modified Eagle medium (DMEM) with B27 (without vitamin A, Invitrogen, basic fibroblast growth factor (10 ng/ml), epidermal growth factor (10 ng/ml), sodium pyruvate and L-glutamine, and 5% FBS. All cultured cells were used within five passages of dissociation.
Characterization of Normal Glial Progenitors
Single cells were sorted using anti-A2B5 
ChIP-sequencing
H3K4me1ChIP was performed from 5 x 10 6 crosslinked p0-CSCs and sequencing libraries were prepared as previously described (Rabbit anti-H3K4me1 Abcam #8895) (Corradin et al., 2014) .
ChIP-seq libraries were sequenced on the Illumina HiSeq 2500 platform at the Case Western Reserve University Genomics Core Facility. The FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) was used to remove adapter sequences and trim read ends using a quality score cutoff of 20. ChIP-seq data were aligned to the hg19 genome assembly (retrieved from http://cufflinks.cbcb.umd.edu/igenomes.html), using Bowtie v0.12.9 (Langmead et al., 2009 ), allowing reads with ≤ 2 mismatches and discarding reads with > 1 reportable alignment ("-m 1" parameter). PCR duplicates were removed using SAMtools (Li et al., 2009a) . Peaks were detected with MACS v1.4 (Zhang et al., 2008) , using an aligned input DNA sample as control. Wiggle tracks stepped at 25 bp were generated by MACS, normalized to the median signal by chromosome and visualized on the UCSC Genome Browser.
Geneset Enrichment Analysis
H3K27ac ChIP-seq enrichment plot centered at the INSERT GENE locus. Enrichment is shown for various normal brain regions (Blue, Roadmap Epigenomics Project), a series of five primary GBMs (Red), GBM stem cells (Purple, n=3, Suva et al., 2014) , and differentiated GBM cells (Green, n=3). The Broad MsigDB databases: C2 canonical, REACTOME, and KEGG pathways were analyzed, along with custom genesets generated previously (Mack et al., 2014) .
Differences between NT shRNA, FTH1 shRNA, and FTL shRNA treatment groups were determined using the default GSEA: signal-to-noise ratio.
Prediction of gene targets of enhancer elements using PreSTIGE
Enhancer-gene assignments were made as described in (Corradin et al., 2014) . Briefly, predictions were made using comparative analysis across a panel of 13 tissues. For an interaction to be predicted the normalized H3K4me1-enhancer signal intensity had to be above background and highly specific to the cell line of interest compared to the remaining 12 cell lines. Additionally, the gene must be within 100-kb of the enhancer and must show relatively cell type-specific transcript levels. PreSTIGE predictions for CSCs were made using independent comparisons to a panel that included bone marrow, cerebellum, embryonic heart, intestine, kidney, liver, lung, MEF, olfactory bulb, placenta, testis and thymus (selected for tissue diversity).
Tissue microarray immunohistochemistry and survival analysis
Briefly, de-identified tissue microarrays (TMAs) were constructed from gliomas after obtaining University of Kentucky Institutional Review Board Approval. Three 2-mm diameter cores per tumor were obtained, with each core embedded in a separate TMA block. A total of 104 cases comprised the TMAs, including 9 nonneoplastic controls (cortical dysplasias), 9 grade II astrocytomas, 11 grade III astrocytomas, 12 anaplastic oligodendrogliomas, 16 grade II oligodendrogliomas, and 47 grade IV glioblastomas (GBMs). Each TMA core was semiquantified on a relative scale from 0 to 3, with 0 = negative and 3 = strongest. Results from all 3 cores were averaged together to produce a final score for a tumor. Results were plotted based on WHO grade and differences were calculated via one-way ANOVA with post-hoc Tukey's test.
Survival data was obtained on each case from the Kentucky Cancer Registry, and the degree of expression was correlated with survival via Log-rank (Mantel-Cox) Tests.
For immunohistochemistry, 5 µm TMA slides were baked at 60°C for 1 hr, followed by deparaffinization in xylene and stepwise hydration in alcohol to TBS-Tween. Endogenous peroxidases were quenched with 3% hydrogen peroxide for 5 min and antigen retrieval was performed with Dako's high pH antigen retrieval buffer by heating to 110°C for 20 min in a Biocare medical decloaking chamber followed by cooling to room temperature. Slides were After washing in TBST, rabbit secondary antibody was applied for 30 min at room temperature (Dako Envision+ kit) followed by TBST washes and detection with DAB. Slides were then counterstained in Mayer's hematoxylin for 5 min and blued in ammonia water before dehydrating and cover slipping.
Ex vivo TF uptake imaging assay
CSCs and non-CSCs were labeled with Cell Tracker Red CMPTX and Cell Trace Far Red DDAO-SE, respectively (Invitrogen). Slice cultures were prepared from non-neoplastic mouse brains, according to prior publications (Stoppini et al., 1991) . 100,000 cells total were transplanted (at a ratio of 1:1) and incubated overnight to ensure integration and survival. 3 hr prior to imaging, slices were incubated in 50 µg/ml fluorescent-TF (Invitrogen). Imaging was done using a SP5 imaging system (Leica) with a 20x liquid immersion objective (numeric aperture of 1.0). Images were acquired at 820 nm and processed using Imaris software (Bitplane).
Iron uptake assay
As previously described (Sarkar et al., 2003) , adherent CSCs and non-CSCs were incubated at 37°C with null NBM medium containing 10 µM 55 Fe-NTA ( 55 FeCl 3 ; Perkin Elmer), 90 µM Fe-NTA (FeCl 3; Sigma-Aldrich), and 100 µM ascorbate for 3 hr. After a PBS wash containing 100 µM EDTA to remove iron non-specifically bound to the cell surface, cells were washed two additional times with PBS, lysed with MP40, transferred to scintillation tubes and counted by liquid scintillation. To measure uptake of iron bound to transferrin (TF), similar procedures were performed as above except that 55 Fe-NTA was first conjugated to TF (Calbiochem) as previously described (Das et al., 2009 ).
Transferrin secretion assay
CSCs and non-CSCs from three xenograft specimens were plated and grown to equal confluency in identical medium conditions (see above). Medium was collected and concentrated using centrifugal filter with a 10K molecular weight cutoff. A BCA protein assay was then used to detect the total amount of protein within the media. 1µg protein from each cell line was added to a transferrin ELISA (Abcam Transferrin Human ELISA Kit)
Thymidine incorporation assay
Thymidine was added in a 4µl:46µl dilution of thymidine: neurobasal medium per well (100,000 cells/well in 12-well plate) and incubated for 4 hr at 37°C. Collected medium was spun at 1500 rpm for 5 min, washed repeatedly with cold PBS and once with cold 10% TCA. After 1 hr incubation in 400µl cold 10% TCA, medium was incubated for 1 hr at 4°C, spun with pellet resuspended in 500µl of 0.2N NaOH. After incubation overnight at RT, medium was transferred to scintillation tubes and quantified using a scintillation counter.
Immunofluorescent staining
Cells or 10µm thick slides of xenografted brain tissue (n ≥ 3) were fixed in 4% paraformaldehyde and immunolabeled using the following antibodies: mouse anti-Transferrin Receptor (TfR/CD71, 1:250, Invitrogen), goat anti-Sox2 (1:500, R&D Systems), rabbit anti-Ferritin Light Chain (FTL, 1:250, Abcam), and rabbit anti-Ferritin Heavy Chain (FTH1, 1:250, Abcam). Primary antibodies were incubated for 16 hr at 4°C, followed by detection by the following secondary antibodies:
Alexa 568 donkey anti-rabbit or donkey anti-mouse (1:1000, Molecular Probes, Invitrogen) and Alexa 488 donkey anti-goat (1:1000, Molecular Probes, Invitrogen). Nuclei were counterstained with DAPI, and slides were mounted using Fluoromount (Calbiochem). Images were taken using either a Leica DM4000 upright microscope (Leica) or a Zeiss LSM 510 Meta Confocal
Microscope. All images were taken and processed with equal settings.
Immunoblotting
Cells were collected and lysed in EBC buffer containing phosSTOP phosphatase inhibitor cocktail (Roche) and protease inhibitor cocktail (Sigma) and separated by a Novex NuPAGE 4- 
Cell viability assay
For all experiments measuring cell viability, cells from dissociated xenografts were plated in triplicate in 96-well tissue culture treated plates at a density of 1000 cells per well. Relative ATP levels were measured at days 0, 1, 3, 5, and 7 days using CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to manufacturer's instructions. Results are reported as relative fold change in ATP with each group internally normalized to its luminescence reading at day 0 (taken 6 hr post-plating). CTGGAGACTCACTTCCTAGAT-3') were validated as the best shRNAs to be used as each exhibited highest knockdown efficiency and no off-target effects.
Lentiviral Transduction
FoxM1 Rescue Assay
CSCs were plated at a density of 1 x 10 5 cells/well in a 24-well plate already pre-coated with geltrex (Life Technologies). Following transduction with NT, FTH1, or FTL shRNAs, CSCs were transfected with FoxM1 overexpression or empty vector constructs. Cellular growth patterns were traced and calculated by taking the average of four measurements per well using the Incucyte Zoom (Essen BioScience).
Transferrin receptor biotinylation assay
Briefly, CSCs and non-CSCs from 4 different xenografts were cultured on geltrex-coated tissue culture plates incubated in identical medium conditions. 20 million cells were washed twice with PBS and pulse-labeled (30 min) with a cell-impermeable, cleavable biotinylation reagent (Sulfo-NHS-SS-Biotin, 0.3 mg/ml) to tag exposed primary amines of proteins in the cellular membrane of CSCs and non-CSCS, respectively. After quenching and cell lysis, biotinylated fraction of proteins was immunoprecipitated using affinity-purified using NeutrAvidin agarose resin. For
Western blot analysis, equal volumes (30 µl) of cytosolic (flow-through, biotin -) and membrane (eluted, biotin + ) fractions were separated on 10% SDS-PAGE gel and probed for TfR (Invitrogen). ERK1/2 was used as a purity control (cytosolic marker) (Hamerlik et al., 2012) .
Flow cytometric analysis and sorting
For TfR expression analysis, freshly dissociated xenografts (n ≥ 6) were incubated with TfR/CD71-PE antibody (BD Biosciences) for 1 hr at dilutions specified in the manufacturer's protocols. A BD FACSAria II sorter (BD Biosciences) was used to select, analyze, and sort TfRpositive and TfR-negative populations. Gating was determined using a LIVE/DEAD viability dye (Invitrogen) and an IgG2A Isotype control (BD Biosciences).
Microarray and microarray analysis
Microarray hybridization and processing were performed at the Case Western Reserve University Genomics Sequencing Core according to the manufacturer's protocol using the GeneTitan multichannel instrument (Affymetrix). Biotinylated cDNA fragments were generated from 500 ng of total RNA, and 180 ng of cDNA was hybridized onto the HuGene 2.1 PEG array (Affymetrix). The HuGene 2.1 array covers > 30,000 coding transcripts and 11,000 long internegic noncoding transcripts. Raw intensity values were normalized by robust multiarray average (RMA) analysis as previously described (Irizarry et al., 2003) using the Bioconductor oligo R package (Carvalho and Irizarry, 2010) . Using the raw gene expression values, fold changes for each gene were calculated between each pair of non-targeting (NT) and FTH1 or FTL shRNA condition. As an input for further analysis, we used only genes that were consistently decreased by 2-fold, with a p value < 0.05. Genes that met this threshold were analyzed using Ingenuity Pathway Analysis (IPA, Ingenuity Systems) with the threshold of a more than 2-fold expression difference. For calculations of mRNA levels for FOXM1 and downstream targets, values were first normalized by RMA analysis followed by fold changes for each gene calculated by comparing expression from non-targeting (NT) shRNA to either FTH1 or FTL shRNA condition within each specimen.
Chromatin Immunoprecipitation
FoxM1 chromatin immunoprecipitation experiments were performed using 5 µg of FoxM1 antibody (GeneTeX) per IP as described previously (Mack et al., 2014) . Predicted FoxM1 binding sites and negative control regions (up-or down-stream) were identified by mining the ENCODE database for published FoxM1 ChIP-seq profiles. 
Statistical analysis and sample sizes
All grouped data are presented as mean ± S.E.M. Difference between groups was assessed by ANOVA with a Bonferroni's post hoc test, Student's t-test, or log-rank (Mantel-Cox), where appropriate, using GraphPad Prism software. For survival analysis, Kaplan-Meier curves were generated and log-rank analysis were also performed using Prism software. We used short-term passage cells (less than 5 passages both in terms of xenograft passage and passage in culture). Typical proportions of CSCs isolated from fresh GBM specimens or xenograft were usually 10% or less than the dissociated tumor bulk. We observed consistent results across all specimens used in this manuscript. For mouse experiments, sample sizes were calculated using the formula n = 1 + 2C (σ/d) 2 , where n = number of animals per arm, C = 7.85
(significance level of 5% with a power of 80%), σ = s.d and d = difference to be detected. For other experiments, no statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those in our previous publications.
